Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Shuttle Pharmaceuticals Holdings Inc., 1 year.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 3, 2026 | Zevra Therapeutics Inc. | Open-market sale | −10,500 | $9.19 | $96,495 |
| Jan 31, 2026 | Zevra Therapeutics Inc. | Option exercise | +35,334 | — | — |
| Jan 30, 2026 | Zevra Therapeutics Inc. | Option exercise | +11,333 | — | — |
| Jan 30, 2026 | Zevra Therapeutics Inc. | Open-market sale | −3,375 | $8.83 | $29,801 |
| Feb 13, 2025 | Zevra Therapeutics Inc. | Open-market sale | −10,500 | $7.86 | $82,530 |
| Jan 31, 2025 | Zevra Therapeutics Inc. | Option exercise | +35,333 | — | — |
| Dec 31, 2024 | Shuttle Pharmaceuticals Holdings Inc. | Grant or award | +209,790 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.